Welcome to our dedicated page for Innovative Hold news (Ticker: IHAI), a resource for investors and traders seeking the latest updates and insights on Innovative Hold stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Innovative Hold's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Innovative Hold's position in the market.
Summary not available.
Summary not available.
Innovative Holdings Alliance, Inc. (OTC PINK:IHAI) announced a strategic Brand License Agreement with M2Bio Sciences Food and Beverage on March 14, 2023. This agreement allows IHAI Brands, Inc., a wholly owned subsidiary, to be the first licensee in the U.S. to market various CBD-infused products, such as Medspresso coffee, Liviana olive oil, and Dr. AnnaRx muscle rubs. The products will be sold via e-commerce, wholesale, retail, and through influencers. This partnership aims to enhance IHAI’s presence in the growing CBD market and reflects the company’s plan for U.S. distribution in 2023.